Danaher | DHR - مصاريف البيع والإدارة

سعر السهم
177.25
التغيير اليومي
-1.32 -0.74%
شهريا
-5.29%
سنويا
-10.09%
Q2 التوقعات
173.46




مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 3.27B 138M 2026-03
Agilent USD 476M 48M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bio Techne USD 113.69M 2.52M 2025-12
Bio-Rad Laboratories USD 206.8M 900K 2025-09
Boston Scientific USD 1.83B 93M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 383M 28M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
ESCO Technologies USD 61.21M 2.13M 2025-12
Fortive USD 417.4M 10.2M 2025-12
Henry Schein USD 808M 48M 2025-12
Illumina USD 283M 27M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
IQVIA Holdings USD 468M 46M 2025-12
Keysight Technologies USD 447M 48M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
Medtronic 2.97B 159M 2025-09
Mettler Toledo International USD 259.83M 11.43M 2025-12
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Quest Diagnostics USD 504M 0 2026-03
Quidel USD 194.4M 7.5M 2025-12
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
Roper Industries USD 884.2M 42.6M 2026-03
Stryker USD 2.14B 150M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Waters USD 240.01M 25.78M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12